Time / Presentation Title/Event / Presenter / CE / Location
7:30am – 2:00pm / Board Meeting / BERKS ROOM
1:00pm / Registration Opens / FOYER
1:00pm / Exhibitor Set Up Begins / EVENT CENTER
2:00pm -3:30pm / PSHP Update and Healthcare Impact on Pharmacy Services
Pharmacist Objectives:
1. Discuss the current topics pertaining to PSHP.
2. Identify and discuss the current healthcare environment and its effects on servicesthat pharmacists provide.
Technician Objectives:
1. Discuss the current topics pertaining to PSHP.
2. Discuss the impact that the current healthcare environment has on the duties andresponsibilities of pharmacy technicians. / Jennifer M. Belavic, PharmD, MBA, BCPS, FASCP / 1.5 / Monroe ROOM
3:30pm – 4:30pm / Implementation of a Specialty Pharmacy
Pharmacist Objectives:
1. What are important roles for Pharmacists within Specialty Pharmacy?
Technician Objectives:
2. What are unique roles for Pharmacy Technicians within Specialty Pharmacy? / Richard Demers, MS, RPh, FASHP &
NishaminyKasbekar, BS, PharmD, FASHP / 1 / Monroe ROOM
4:30pm- 6:00pm / Update of Antidiabetic Medications
Pharmacist Objectives:
1. Review the major pathophysiologic defects in Type 2 Diabetes and targeted sites for medications
2. Describe the newer antidiabetic medication classes along with specific agents within the classes.
Technician Objectives:
Technicians will recognize these newer agents in the course of carrying out their duties / Robert W. Rossi, RPh, CDE / 1.5 / Monroe ROOM
4:30pm- 6:00pm / Reverse Trade Show / EVENT CENTER
6:00pm- 7:00pm / Cocktail Reception with Exhibits Open / EVENT CENTER
7:00pm- 8:00pm / Sponsored Product Theater Dinner / Monroe Room
TOTAL CE: 4
Thursday October 16, 2014
Time / Presentation Title/Event / Presenter
7:00am - 8:00am / Novo Nordisk Sponsored Breakfast
Redefining the Use of Basal Insulin: Combining Sustained Action with QD Efficacy / DeebeanneTavani, DO, PhD / EVENT CENTER/Buck Room
8:00am - 9:00am / Moving Beyond the Tipping Point
Pharmacist Objectives:
1. Discuss Pharmacy Report to the U.S. Surgeon General
2. Express transformative thinking based on current
health system needs and pharmacy practice
3. Explain the importance of facilitating partnerships at the state level to help transform the profession
4. Explain a call-to-action that will improve the Nation’s health
Technician Objectives:
1. Discuss Pharmacy Report to the U.S. Surgeon General
2. Express transformative thinking based on current
health system needs andpharmacy practice
3. Explain the importance of facilitating partnerships at the state level to helptransform the profession
4. Explain a call-to-action that will improve the Nation’s health / Scott Giberson, RPh, PhC, MPH, DSci (H)
Rear Admiral, US Public Health Service, Acting US Deputy Surgeon General
Chief Professional Offer, Pharmacy / 1 / Monroe ROOM
9:00am – 10:00am / Pharmacy Practice Advancement: How Far We’ve Come…What’s Coming Next
Pharmacist Objectives:
1. Define practice model and how the Pharmacy Practice Model Initiative (PPMI) can help advance practice models in hospitals.
2. Identify key drivers of pharmacy practice changeover the past 50 years.
3. Explain how the availability of qualified pharmacy technicians will play a pivotalrole in enabling the advancement of pharmacist practice.
4. Describe the changes in adoption of automation and technology and how itcreates new opportunities for pharmacy
5. Describe a how you can use the information presented to evaluate andadvance practice of pharmacists and technicians inyour setting practice setting
Technician Objectives:
1. Define practice model and how the Pharmacy Practice Model Initiative (PPMI)can help advance practice models in hospitals.
2. Identify key drivers of pharmacy practice changeover the past 50 years.
3. Explain how the availability of qualified pharmacy technicians will play a pivotalrole in enabling the advancement of pharmacist practice
4. Describe the changes in adoption of automation and technology and how itcreates new opportunities for pharmacy.
5. Describe a how you can use the information presented to evaluate andadvance practice of pharmacists and technicians inyour setting practice setting / Douglas Scheckelhoff, MS, FASHP / 1 / Monroe ROOM
10:00am - 11:30am / Exhibit Hall / EVENT CENTER
11:30am -12:30pm / Lunch / EVENT CENTER
12:30pm - 1:30pm / Considerations in Outsourcing Sterile Compounded Products
Pharmacist Objectives:
1. Demonstrate an understanding of updated regulations
regarding compoundingpharmacies
2. Explain the considerations that should be evaluated
when deciding to outsourcecompounded products
Technician Objectives:
1. Recall the regulatory requirements necessary when outsourcing compounded sterileproducts
2. Describe the quality assurance requirements of an outsourced compoundingpharmacy / Matthew W. Eberts, PharmD, MBA, FASHP / 1 / Monroe ROOM
1:30pm- 2:30pm / Advocacy for Pennsylvania Pharmacists
Pharmacist Objectives:
1. List PSHP Advocacy Activities that have occurred
2. Describe your role in Advocacy or the legislative process
Understand the importance of advocacy to the pharmacy community and public.
Technician Objectives:
1. List PSHP Advocacy activities
2. Describe the process of a bill
3. Explain how to speak to your representative or Senator / Michele C. Musheno, MS, RPh / 1 / Monroe ROOM
2:30pm – 2:45pm / Break
2:45pm – 4:45pm / Current Topics in Hospital Pharmacy-
Patient Safety Clinical Pearls
Medication Safety Initiatives
Pediatric Pharmacokinetic Pearls
Evaluating the Quality of Dietary Supplements
For Pain or Not for Pain: Methadone Madness
Inhaled epoprostenol: Clinical and practical considerations
Pharmacists as a Safety Measure in the Emergency Department
Standardizing Compounded Pediatric and Neonatal Medications
Pharmacist Objectives:
1. Discuss medication safety initiatives incorporated into practice at my institution
2. Identify barriers for implementation of safety initiatives
3. Review measures for success and data collection
for safety initiatives
4. Review pharmacokinetic differences among the pediatric age categories.
5. Describe elements involved in pharmacogenetic influences onpharmacodynamics.
6. Describe the potential quality problems with thecurrent dietary supplements onthe market.
7. List examples of dietary supplement quality issues that have been reported bythe FDA in the past year.
8. Discuss the various processes that can be used to evaluate the quality of dietarysupplements.
9. Review one standard operating procedure for evaluating the quality of a dietarysupplement.
10. Describe factors that make the Emergency Department one of the mostdangerous places to receive healthcare
11. Illustrate how pharmacist presence in the ED setting can prevent medicationerrors
12. Using patient case examples, demonstrate medication safety events that canoccur as a result of having multiple compounded drug concentrations
13. Describe safety initiatives aimed at standardization of compoundedintravenous infusions and compounded oral liquids
Technician Objectives:
1. Discuss medication safety initiatives incorporated into practice at my institution
2. Identify barriers for implementation of safety initiatives
3. Review measures for success and data collectionfor safety initiatives
4. Show various parameters that are under consideration when making dosingdecisions for pediatric patients of different ages / Clinical Pearls
Laura Haynes, PharmD, BCPS
Jenny Boucher, BS, PharmD, JD, BCPS
Sarah C. Erush, PharmD, BCPS
Maria Foy, PharmD, BCPS, CPE
Peter Hlavinka, PharmD, BCPS
Christopher Shaw, PharmD, BCPS
Laura Hayn, PharmD, BCPS / 2 / Monroe ROOM
Total CEs: 6
5:30pm – 7:00pm / Awards Reception / VISION BAR
Friday October 17, 2014
Time / Presentation Title/Event / Presenter / CE / Location
7:00am – 8:00am / Breakfast / EVENT CENTER
8:00am- 9:00am / Pain is Such a Pain
(1 hour of patient safety CE)
Pharmacist Objectives:
1. Review the scope of opioid related harm in hospitalized
patients
2. Review regulatory recommendations and requirements
for the appropriate useand monitoring of opioids in a hospitalized patient
3. Review types of diversion and methods to identify
Technician Objectives:
1. Review some common look-alike sound-alike high riskerrors that can occur inhospitalized patients.
2. Review potency differences of various high-risk opioids / Charles J. Medico, PharmD, BCPS / 1 / Monroe ROOM
9:00am -12:00pm / Student Leadership Development Workshop / Elaine Mebel Strauss, PharmD, MS / Foundry ROOM
9:00am – 10:00am / The Best of Times: Pharmacy in an Era of Accountable Care
Pharmacist Objectives:
1. Describe the role of pharmacists in accountable care organizations (ACO)
2. List four key areas to address when developing an ambulatory care practice
3. Describe activities of a care transition pharmacist
4. List 3 resources to assist with planning pharmacy services in an ACO
Technician Objectives:
1. Describe the role of pharmacists in accountablecare organizations (ACO)
2. Describe activities of a care transition pharmacist
3. List 3 resources to assist with planning pharmacy services in an ACO / Toni Fera, BS, PharmD
Independent Healthcare Consultant / 1 / Monroe ROOM
10:00am – 10:30am / Break
10:30am-11:30am / Developments in the Treatment of Hepatitis C: A New Era
Pharmacist Objectives:
1. Summarize the results of clinical trials for the newest medications approved forHepatitis C treatment and where these medications fit into treatment decisions.
2. Discuss how to develop a clinical pharmacist program for the treatment of Hepatitis C and become an integral part of the treatment team.
3. Apply knowledge of the medication options for Hepatitis C to patient cases.
Technician Objectives:
1. Summarize the results of clinical trials for the newest medications approved for Hepatitis C treatment and where these medications fit into treatment decisions.
2. Discuss how to develop a clinical pharmacist program for the treatment of Hepatitis C and become an integral part of the treatment team.
3. Apply knowledge of the medication options for hepatitis C to patient cases. / Nancy Love, PharmD, BCPS / 1 / Monroe ROOM
11:30am – 12:30pm / Student and Resident Integration into Innovative Collaborative Pharmacy Practice Models
Pharmacist Objectives:
1. Discuss how inter-professional education (IPE) learning experiences preparegraduates to develop meaningful partnerships and add value to your institution.
2. Describe opportunities for student and residentinvolvement in aninterprofessional group medical visit practicemodel.
3. Describe resident and student involvement in themedication reconciliation anddischarge processes at an urban, teaching medical center.
4. Identify opportunities for student and residentresearch involvement associated with the medication reconciliation and discharge processes.
5. Identify three opportunities to integrate student pharmacists and residents into a transitions of care (TOC) model that incorporates a community hospital andpharmacy.
Technician Objectives:
1. Discuss how interprofessional education (IPE) learning experiences preparegraduates to develop meaningful partnerships and add value to your institution.
2. Describe opportunities for student and residentinvolvement in aninterprofessional group medical visit practicemodel.
3. Describe resident and student involvement in themedication reconciliation anddischarge processes at an urban, teaching medical center.
4. Identify opportunities for student and residentresearch involvement associatedwith the medication reconciliation and discharge processes.
5. Identify three opportunities to integrate student pharmacists and residents into atransitions of care (TOC) model that incorporates a community hospital andpharmacy. / Jane Bowen, PharmD, BCPS
Gladys Dueñas, PharmD, BCACP
Valerie Ganetsky, PharmD, BCPS
Anisha Grover, PharmD, BCACP
Karleen Melody, PharmD, BCACP
Sanchita Sen, PharmD, BCPS / 1 / Monroe ROOM
TOTAL CEs: 4
Total CEs if you attend the full conference: 14